Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2009, for Spatializer Audio Laboratories, Inc. (Note: The input metadata listed "Enveric Biosciences," but the filing text explicitly identifies the registrant as Spatializer Audio Laboratories, Inc.). The Company ceased commercial operations in 2006 after selling substantially all of its intellectual property assets to DTS, Inc. in July 2007. Currently, the Company operates as a shell entity seeking merger, acquisition, or business combination opportunities. The filing raises substantial doubt about the Company's ability to continue as a going concern due to significant operating losses and limited cash reserves.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 | Dec 31, 2008 (Balance Sheet) |
|---|---|---|---|
| Revenue | $0 | $0 | N/A |
| Operating Expenses | $16,691 | $70,682 | N/A |
| Net Loss | $(21,716) | $(64,391) | N/A |
| EPS (Basic & Diluted) | $(0.00) | $(0.01) | N/A |
| Cash and Cash Equivalents | $35,845 | $1,527,128 | $66,833 |
| Working Capital | $26,753 | N/A | $48,469 |
| Total Assets | $35,845 | N/A | $69,675 |
| Total Liabilities | $9,092 | N/A | $21,206 |
| Shares Outstanding | 6,500,000 | 6,500,000 | 6,500,000 |
Debt and Liquidity: The Company has no long-term debt. Current liabilities consist primarily of accounts payable ($7,466) and accrued professional fees ($16,000). Cash flow from operating activities was negative $30,988 for the quarter. Financing activities included a repayment of notes payable of $9,680.
Material Changes vs. Prior Period
- Expense Reduction: Operating expenses decreased significantly from $70,682 in Q1 2008 to $16,691 in Q1 2009, attributed to the suspension of operations and reduced general and administrative costs.
- Cash Depletion: Cash and cash equivalents declined from $66,833 at the end of 2008 to $35,845 at March 31, 2009, a reduction of approximately 46% in one quarter.
- Liability Fluctuation: Total current liabilities decreased from $21,206 (Dec 31, 2008) to $9,092 (Mar 31, 2009), driven by a reduction in accrued professional fees and accrued expenses, partially offset by an increase in accounts payable.
- Net Loss Improvement: The net loss narrowed to $21,716 from $64,391 in the prior year quarter, reflecting the lower expense base.
Outlook, Risks, and Management Commentary
- Going Concern: Management explicitly states that current circumstances raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include adjustments that might result from this uncertainty.
- Liquidity Risk: Management believes current cash reserves are insufficient to meet operating obligations for more than 3 to 6 months without raising additional capital. There is no current source of future cash flow.
- Strategic Direction: The Company plans to continue as a public entity solely to seek merger, acquisition, or business combination opportunities. No significant operations are expected until such a transaction is effectuated.
- Tax Assets: The Company holds net operating loss (NOL) carryforwards of approximately $26.2 million. However, due to a change in control, it is expected that these NOLs will not be utilized to offset taxable income generated after 2007.
- Legal Proceedings: As of May 10, 2009, there are no pending legal proceedings expected to have a material adverse effect, though litigation risks remain inherent.
Investor Verification Checklist
- Cash Runway: Verify the accuracy of the 3-6 month liquidity estimate given the current cash balance of $35,845 and monthly burn rate.
- Capital Raising: Confirm if any definitive agreements or active efforts are underway to raise the additional capital required to maintain public listing status.
- Shell Status: Review the Company's status as a "shell company" and any potential regulatory hurdles to future mergers or acquisitions.
- Accrued Fees: Investigate the nature of the $16,000 in accrued professional fees to ensure no undisclosed obligations exist.
- Stock Liquidity: Assess the trading volume and liquidity of the 6.5 million outstanding shares, as the Company notes the market may not remain liquid.